Wael Emad Eid

Wael Emad Eid

Auto-generated profile, based on publicly available information

Wael Emad Eid

St. Elizabeth Physicians Regional Diabetes Center, Covington, Kentucky, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in Journal of Diabetes Science and Technology
Verified
Journal Article
Open access
PDF file
Omar El-GayarOmar El-Gayar
Omar El-Gayar
PTPrem Timsina
Prem Timsina
NNNevine Nawar
Nevine Nawar
WEWael Eid
Wael Eid
Background: Advancements in smartphone technology coupled with the proliferation of data connectivity has resulted in increased interest and unprecedented growth in mobile applications for diabetes self-management. The objective of this article is to determine, in a systematic review, whether diabetes applications have been helping patients with type 1 or type 2 diabetes self-manage their condition and to identify issues necessary for large-scale adoption of such interventions. Methods: The review covers commercial applications available on the Apple App Store (as a representative of commercially available applications) and articles published in relevant databases covering a period from January 1995 to August 2012. The review included all applications supporting any diabetes self-management task where the patient is the primary actor. Results: Available applications support self-management tasks such as physical exercise, insulin dosage or medication, blood glucose testing, and diet. Other support tasks considered include decision support, notification/alert, tagging of input data, and integration with social media. The review points to the potential for mobile applications to have a positive impact on diabetes self-management. Analysis indicates that application usage is associated with improved attitudes favorable to diabetes self-management. Limitations of the applications include lack of personalized feedback; usability issues, particularly the ease of data entry; and integration with patients and electronic health records. Conclusions: Research into the adoption and use of user-centered and sociotechnical design principles is needed to improve usability, perceived usefulness, and, ultimately, adoption of the technology. Proliferation and efficacy of interventions involving mobile applications will benefit from a holistic approach that takes into account patients' expectations and providers' needs.

1 August 2013 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
Omar El-GayarOmar El-Gayar
Omar El-Gayar
PTPrem Timsina
Prem Timsina
NNNevine Nawar
Nevine Nawar
WEWael Eid
Wael Eid

28 April 2022 in International Journal of Medical Informatics
Verified
Journal Article
Open access
QLQi Li
Qi Li
ACAlina Campan
Alina Campan
ARAi Ren
Ai Ren
WEWael E. Eid
Wael E. Eid
The ACC/AHA Pooled Cohort Equations (PCE) Risk Calculator is widely used in the US for primary prevention of atherosclerotic cardiovascular disease (ASCVD), but may under- or over-estimate risk in some populations. We therefore designed an automated, population-specific ASCVD risk calculator using machine-learning (ML) methods and electronic medical record (EMR) data, and compared its predictive power with that of the PCE calculator. We collected data from 101,110 unique EMRs of living patients from January 1, 2009 to April 30, 2020. ML techniques were applied to patient datasets that included either only cross-sectional (CS) features, or CS combined with longitudinal (LT) features derived from vital statistics and laboratory values. We compared the utility of the models using a proposed new cost measure (Screened Cases Percentage @ Sensitivity level). All ML models tested achieved better predictive power than the PCE risk calculator. The random forest ML technique (RF) applied on the combination of CS and LT features (RF-LTC) produced the best area under curve (AUC) score of 0.902 (95% confidence interval (CI), 0.895-0.910). To detect 90% of all positive ASCVD cases, the best ML model required screening only 43% of patients, while the PCE risk calculator required screening 69% of patients. Prediction models built using ML techniques improved ASCVD prediction and reduced the number of screenings required to predict ASCVD when compared with the PCE calculator, alone. Combining LT and CS features in the ML models significantly improved ASCVD prediction compared with using CS features, alone.

1 March 2004 in Endocrine Practice
Verified
Journal Article
Closed access
WEWael Eid
Wael Eid
TWThomas M. Wheeler
Thomas M. Wheeler
MSMorali D. Sharma
Morali D. Sharma

1 October 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
WEWael E. Eid
Wael E. Eid
ESEmma Hatfield Sapp
Emma Hatfield Sapp
TMTamuchin McCreless
Tamuchin McCreless
JNJoseph R. Nolan
Joseph R. Nolan
EFElijah Flerlage
Elijah Flerlage

6 December 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
WEWael E Eid
Wael E Eid
ESEmma Hatfield Sapp
Emma Hatfield Sapp
AWAbby Wendt
Abby Wendt
ALAmity Lumpp
Amity Lumpp
CMCarl Miller
Carl Miller
Context: Familial hypercholesterolemia (FH) confers a greatly increased risk for premature cardiovascular disease, but remains very underdiagnosed and undertreated in primary care populations. Objective: We assessed whether using a hybrid model consisting of 2 existing FH diagnostic criteria coupled with electronic medical record (EMR) data would accurately identify patients with FH in a Midwest US metropolitan healthcare system. Methods: We conducted a retrospective, records-based, cross-sectional study using datasets from unique EMRs of living patients. Using Structured Query Language to identify components of 2 currently approved FH diagnostic criteria, we created a hybrid model to identify individuals with FH. Results: Of 264 264 records analyzed, between 794 and 1571 patients were identified as having FH based on the hybrid diagnostic model, with a prevalence of 1:300 to 1:160. These patients had a higher prevalence of premature coronary artery disease (CAD) (38-58%) than the general population (1.8%) and higher than those having a high CAD risk but no FH (10%). Although most patients were receiving lipid-lowering therapies (LLTs), only 50% were receiving guideline-recommended high-intensity LLT. Conclusion: Using the hybrid model, we identified FH with a higher clinical and genetic detection rate than using standard diagnostic criteria individually. Statin and other LLT use were suboptimal and below guideline recommendations. Because FH underdiagnosis and undertreatment are due partially to the challenges of implementing existing diagnostic criteria in a primary care setting, this hybrid model potentially can improve FH diagnosis and subsequent early access to appropriate treatment.